跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROBITUSSIN DM SYRUP - HSA Drug Approval Details
Approvals
/
HSA
/
ROBITUSSIN DM SYRUP
Approved
THERAPEUTIC
ROBITUSSIN DM SYRUP
INTERPHIL LABORATORIES INC (PHILIPPINES)
🇸🇬 Health Sciences Authority
Approval Date
Mar 7, 2003
Approval ID
fbe0cb9fff7d2e81
Company
INTERPHIL LABORATORIES INC (PHILIPPINES)
Type
Therapeutic
Approval Details
Approval Id
fbe0cb9fff7d2e81
Drug Name
ROBITUSSIN DM SYRUP
Product Name
ROBITUSSIN DM SYRUP
Approval Number
SIN12222P
Approval Date
2003-03-07
Registrant
HALEON SINGAPORE PTE. LTD.
Licence Holder
HALEON SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R05CA10
Atc Item Name
combinations
Pharma Manufacturer Name
gsk consumer healthcare singapore pte. ltd.
Active Ingredients
DEXTROMETHORPHAN HBr
30 mg/10 ml
GUAIPHENESIN
200 mg/10 ml
DEXTROMETHORPHAN HBr
30 mg/10 ml
GUAIPHENESIN
200 mg/10 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 7, 2003
Approval ID
fbe0cb9fff7d2e81
Type
Therapeutic
Back to HSA Approvals